Font Size: a A A
Keyword [Targeting agents]
Result: 1 - 20 | Page: 1 of 2
1. Cooperative Antitumor Effects Of Monkshood Polysaccharide Or RhIL-2 With Adriamycin Different Targeting Agents
2. Study Of Combretastatin A4Phosphate Analogues Antineoplasm In Vitro And In Vivo
3. Nuclide Imaging Of Tumor Using Angiogenesis-targeting Agents Labelled With ~(131)I In Tumor-bearing Nude Mice
4. The Microtube-targeting Agents Induced Autophagy/autophagic Cell Death And Its Relationship With Apoptotic Sensibility In Human Gastric Cancer Cells
5. Delay Colonic Ph-sensitive Targeting Agents
6. The Mesylate Dihydroergotoxine Nasal Brain Targeting Agents
7. The Study Of The Nano-targeting Agents Of Paclitaxel By The Delivery Of Single Wall Carbon Nanotubes
8. Killing Effect And Its Mechanisms Of Micro-tubule Protcin Inhibitor CYT997on Acute Myeloid Leukemia Cell
9. Study On The Anti-Tumor Activity And Mechanism Of LL-01 And LL-02, Novel Microtubule Targeting Agents
10. The Effect Of Apoptosis Inhibitory Protein Targeting Agents LCL161 And YM155 On Radiosensitivity Of Esophageal Cancer And Its Mechanism
11. Efficacy Of First-line Treatment Of Chemotherapy And Chemotherapy Plus Targeting Agents For MCRC
12. Abnormal Mitochondrial Metabolism Contributes To Drug Resistance Of Prostate Cancer And Intervention Mechanism Of Targeting Agents
13. Design,synthesis And Biological Evaluation Of Tubulin Inhibitors As Antitumor Agents Targeting The Colchicine Binding Site
14. Research On Antitumor Mechanism Of Microtubule Destabilizing Agents And Molecular Marker GPC1
15. Establishment Of A Clear-cell Renal Cancer Cell Tumor Xenograft Model By Using Patient-derived Cells To Examiningt Cell Sensitivity To Molecular-targeting Agents
16. Inhibitory Effect Of Zuojin Pills Combined With EGFR-targeted Polypeptide MM2 In Intestinal Cancer
17. Studies of molecular targeting agents and cytokines on T cells: Implications in murine acute graft-versus-host disease
18. Combinatorial targeting of the glucagon-like peptide-1 and sulfonylurea-1 receptors using a complimentary mulitvalent glucagon-like peptide-1/glibenclamide ligand for the improvement of beta-cell targeting agents and diabetic treatment
19. Investigation of the effect of physical parameters on the design of tumour targeting agents
20. An in vitro study of the mechanisms that underlie changes in neuronal sensitivity and neurite morphology following treatment with microtubule targeting agents
  <<First  <Prev  Next>  Last>>  Jump to